News Focus
News Focus
icon url

Celtics2011

06/30/13 8:29 AM

#3207 RE: Snizzle #3206

The reality snizzle all the hard work done in regards to float!!!! 1.2m to .60!
icon url

tryz

06/30/13 8:31 AM

#3208 RE: Snizzle #3206

Snizzle...SCRC only a matter of time before this attracts financial anylysts also and there recommend-buy reports and coveradges.....Epic!!!........imo,tryz
icon url

Talc Moan

06/30/13 8:47 AM

#3209 RE: Snizzle #3206

The Sizzle before the Snizzle!
icon url

Celtics2011

06/30/13 8:59 AM

#3212 RE: Snizzle #3206

#1. float 8m approx imo all locked

#2. 8m revenues currently projection 2013 BY THE COMPANY 10m ( That projection was before the DPG pact signed this week for the big boxes. WMT! WAG! CVS! KROGERS!

#3. Noteholders continental and gel away from the market as the CEO of SCRC decided to pay off the notes early and take the prepayment penalty in the best interests of shareholders.

#4. In aug/sept shipping for Rapimeds(the replacement product for JNJ'S baby tylenol who is removed until q4 2014 possible longer due to liver failure.) In the store front Sept/oct 2013.

#5. Rapimeds dissolves in 20 seconds and can be applied to 50 FDA approved products. Vitamins,sleeping pills,pms, and VIAGRA. It will revolutinalize the way meds are given frever in a much more expedious manner and safe.

#6. Purchase order financing is now available thru DPG for the big boxes. I believe the vig charged by DPG 10% to 12% to do everything imo.

#7. Pfizer coming off patent this year I believe. I have not factored Rapimed Viagra into the equation as we will have to see where SCRC goes with the erectile dysfuction market in China. We will watch any future developments in China to get some indication where we are on the 3 minute viagra what I like to call it.

#8. The medical coomunity is endorsing SCRC's Rapimed delivery system. We have heard about Pharmacist,Dr's,Rn's, and guys/girls in the sales field from amgn and fpizer endorsing this.

#9. My projuction for 2014. I believe with DPG secured scrc will do 25m in revenues 2014. at 12x sales thats a 300m valuation. Currently we have approcx 62m shares os (outstanding) so with expansion factor in 75m os next year thats 300m valuation divided bt the 75m os you arrive at a forward looking # at $4 a share for SCRC and very profitable. 10x your $$$$$$ from here.

#10. this is not a dream after DPG this week as our distributor this has become a reality. As peter Lych said years ago at Fidelity Magellan: If you can smell it, feel it, taste it, touch it, then buy it!. This is the next mini glaxo at under $1 that you can buy. Remeber SCRC has 50 other fda products so apply 25m domestically at ZERO GROWTH thats 25mx50= Billions.
icon url

StockBull

06/30/13 7:00 PM

#3247 RE: Snizzle #3206

Haha, everyone I told about SCRC decided to get shares, once they saw the potential and did even a little digging they knew this was a winner.

All people have to do is connect the dots here, two former employees of Pfizer are now associated with Scrips and Capricorn, DPG Distribution deal with huge revenue potentials, notes being paid off ahead of time in order to prevent them from being sold on the market. We have a real product with real revenues and have the potential to be even bigger thanks to various medications which will benefit from the Rapimed technology.

Once someone is told about this, it pretty much speaks for itself afterwards. Good Luck to us!

ShocknAwe!!!